All Stories

  1. Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation
  2. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
  3. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
  4. Has the time come to reevaluate prognostic factors and to rebuild staging systems for Multiple Myeloma?
  5. Aggressive relapses in multiple myeloma revealed by free light chain or total paraprotein escape
  6. Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity